Testosterone and Cardiovascular Risk: TRAVERSE Trial and New FDA Label Change
Mohit Khera, MD, MBA, MPH, discusses testosterone therapy and cardiovascular risk, focusing on the TRAVERSE trial and FDA label changes.
Read MoreSelect Page
by Mohit Khera, MD, MBA, MPH | Apr 2025
Mohit Khera, MD, MBA, MPH, discusses testosterone therapy and cardiovascular risk, focusing on the TRAVERSE trial and FDA label changes.
Read Moreby Jay Simhan, MD, FACS | Apr 2025
Jay Simhan, MD, FACS, explores the challenges of post-radiation bladder neck and proximal urethral strictures.
Read Moreby Mitchell R. Humphreys, MD | Feb 2025
Mitchell R. Humphreys, MD, MPH, delves into benign prostatic hyperplasia management and holmium laser enucleation (HoLEP).
Read Moreby Fernando Tardelli, MD | Feb 2025
Fernando Tardelli, MD, explores penile enlargement, particularly using hyaluronic acid (HA) fillers as a minimally invasive approach.
Read Moreby Arthur L. Burnett II, MD, MBA, FACS | Feb 2025
Arthur L. Burnett II, MD, MBA, FACS, reflects on over 30 years of research on priapism.
Read Moreby Gerald L. Andriole, Jr., MD | Feb 2025
Gerald L. Andriole, Jr., MD, challenges misconceptions about 5-ARIs in urology, focusing on their role in prostate cancer.
Read Moreby Jay Simhan, MD, FACS | Feb 2025
Jay Simhan, MD, FACS, examines the challenges of penile implants in patients with refractory erectile dysfunction and Peyronie’s disease.
Read Moreby Brian J. Flynn, MD | Feb 2025
Brian J. Flynn, MD, explores advancements in treating male stress urinary incontinence, and the shift toward passive and adjustable devices.
Read Moreby Amy Krambeck, MD | Feb 2025
Amy E. Krambeck, MD, discusses HoLEP morcellation and its associated complications, emphasizing procedural refinements and patient safety.
Read Moreby Faysal A. Yafi, MD, FRCSC | Feb 2025
Faysal A. Yafi, MD, FRCSC, discusses minimally invasive surgical procedures and their impact on sexual dysfunction.
Read Moreby Stephen R. Kraus, MD, MBA, FACS | Feb 2025
Stephen R. Kraus, MD, MBA, FACS, provides a comprehensive review of urodynamics, discussing key concepts and practical applications in evaluating lower urinary tract function. This 14-minute presentation emphasizes the importance of understanding both the storage and emptying phases of bladder function.
Dr. Kraus details how dysfunction can arise from a bladder issue, an outlet problem, or both. Specific examples are given and complex cases are also included. Kraus notes results from various tests, such as those for stress incontinence, overactive bladder, and neurogenic bladder, help guide the use of urodynamics in clinical practice. He highlights the need for careful interpretation of test results to ensure accurate diagnosis and treatment planning.
Read Moreby Jeffrey C. Morrison, MD | Feb 2025
Jeffrey C. Morrison, MD, addresses post-vasectomy pain syndrome (PVPS) following vasectomy. In this 11-minute presentation, he highlights the significant challenge PVPS presents to patients and clinicians, emphasizing that a broad differential and comprehensive workup, including physical exams and diagnostic tests, is essential.
Although the cause of PVPS remains uncertain, Dr. Morrison discusses possible contributing factors, such as neuropathic, obstructive, or immune-driven etiologies. He presents treatments, both conservative approaches like scrotal support and anti-inflammatory medications, and options like neuromodulator therapy, pelvic floor physical therapy, and acupuncture.
Dr. Morrison also discusses treatment for those who require additional management, such as spermatic cord block, and surgical options, including microdenervation and vasectomy reversal.
Read More